Skip to content

Gross margin at other companies

Abbott logo
AbbottABT
56.3%+0.4pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp
TFX
TeleflexTFX
38.2%-3.0pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
67.8%-0.5pp
Stryker logo
StrykerSYK
63.8%-0.1pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's gross margin?
Merit Medical Systems (MMSI) reported gross margin of 48.7% in Q1 2026.
How has Merit Medical Systems's gross margin changed year-over-year?
Merit Medical Systems's gross margin increased by 1.9% year-over-year, from 47.8% to 48.7%.
What is the long-term trend for Merit Medical Systems's gross margin?
Over 5 years (2020 to 2025), Merit Medical Systems's gross margin has grown at a 3.2% compound annual growth rate (CAGR), from 41.6% to 48.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.